LA JOLLA, Calif.--(BUSINESS WIRE)--March 1, 2006--Stratagene Corporation (NASDAQ:STGN), a developer, manufacturer and marketer of specialized life science research and diagnostic products, announced today that its Board of Directors has appointed Peter Ellman (age 50) as a new independent board member. The Company also announced that J. David Tholen (age 61), who has been a board member since June 2004, is retiring from the Board effective with Mr. Ellman’s appointment. With Mr. Ellman’s appointment, board membership will remain at five.
